|Other Names||Carboxypeptidase A1, CPA1, CPA|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP6560a was selected from the N-term region of human CPA1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Carboxypeptidase that catalyzes the release of a C- terminal amino acid, but has little or no action with -Asp, -Glu, -Arg, -Lys or -Pro.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Three different forms of human pancreatic procarboxypeptidase A have been isolated. CPA1 is a monomeric pancreatic exopeptidase involved in zymogen inhibition.
Pallares,I., Acta Crystallogr. D Biol. Crystallogr. D64 (PT 7), 784-791 (2008)Bonora,E., Mol. Psychiatry 7 (3), 289-301 (2002)
If you have any additional inquiries please email technical services at email@example.com.